Detailed information for compound 1186272

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 293.702 | Formula: C14H12ClNO4
  • H donors: 1 H acceptors: 2 LogP: 2.68 Rotable bonds: 4
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1c(OC)[nH]cc(c1=O)C(=O)c1ccccc1Cl
  • InChi: 1S/C14H12ClNO4/c1-19-13-12(18)9(7-16-14(13)20-2)11(17)8-5-3-4-6-10(8)15/h3-7H,1-2H3,(H,16,18)
  • InChiKey: GVVWTMUQMUDUMP-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Onchocerca volvulus Pyruvate kinase homolog 0.0032 0.1066 0.5
Brugia malayi exodeoxyribonuclease III family protein 0.0019 0.0147 0.0058
Plasmodium vivax pyruvate kinase, putative 0.0032 0.1066 1
Plasmodium falciparum ataxin-2 like protein, putative 0.0028 0.0785 0.7367
Toxoplasma gondii exonuclease III APE 0.0019 0.0147 0.1379
Loa Loa (eye worm) pyruvate kinase-PB 0.0023 0.0403 0.039
Brugia malayi Pyruvate kinase, M2 isozyme 0.0032 0.1066 0.1449
Entamoeba histolytica pyruvate kinase, putative 0.0023 0.0403 0.2208
Echinococcus multilocularis pyruvate kinase 0.0032 0.1066 0.1066
Entamoeba histolytica hypothetical protein 0.0036 0.1307 1
Onchocerca volvulus Pyruvate kinase homolog 0.0032 0.1066 0.5
Echinococcus granulosus Basic leucine zipper bZIP transcription 0.0036 0.1307 0.1307
Chlamydia trachomatis pyruvate kinase 0.0032 0.1066 0.5
Echinococcus multilocularis pyruvate kinase 0.0026 0.0605 0.0605
Loa Loa (eye worm) pyruvate kinase 0.0032 0.1066 0.1399
Loa Loa (eye worm) transcription factor SMAD2 0.0116 0.6713 1
Trichomonas vaginalis pyruvate kinase, putative 0.0032 0.1066 1
Trypanosoma cruzi pyruvate kinase 2, putative 0.0032 0.1066 1
Giardia lamblia Endonuclease/Exonuclease/phosphatase 0.0019 0.0147 0.1379
Loa Loa (eye worm) pyruvate kinase 0.0032 0.1066 0.1399
Trichomonas vaginalis pyruvate kinase, putative 0.0032 0.1066 1
Brugia malayi MH2 domain containing protein 0.0116 0.6713 1
Toxoplasma gondii pyruvate kinase PyK1 0.0032 0.1066 1
Giardia lamblia Pyruvate kinase 0.0032 0.1066 1
Leishmania major pyruvate kinase 0.0032 0.1066 1
Echinococcus granulosus pyruvate kinase 0.0032 0.1066 0.1066
Trypanosoma brucei pyruvate kinase 1 0.0032 0.1066 1
Trypanosoma brucei PAB1-binding protein , putative 0.0028 0.0785 0.6946
Plasmodium falciparum AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.0019 0.0147 0.1379
Echinococcus granulosus DNA apurinic or apyrimidinic site lyase 0.0019 0.0147 0.0147
Leishmania major hypothetical protein, conserved 0.0028 0.0785 0.6946
Schistosoma mansoni hypothetical protein 0.0036 0.1307 0.1307
Schistosoma mansoni ap endonuclease 0.0019 0.0147 0.0147
Plasmodium vivax ataxin-2 like protein, putative 0.0028 0.0785 0.7367
Trypanosoma cruzi PAB1-binding protein , putative 0.0028 0.0785 0.6946
Echinococcus multilocularis DNA (apurinic or apyrimidinic site) lyase 0.0019 0.0147 0.0147
Trypanosoma cruzi PAB1-binding protein , putative 0.0028 0.0785 0.6946
Mycobacterium ulcerans pyruvate kinase 0.0032 0.1066 1
Treponema pallidum exodeoxyribonuclease (exoA) 0.0019 0.0147 0.5
Entamoeba histolytica hypothetical protein 0.0036 0.1307 1
Trypanosoma brucei pyruvate kinase 1, putative 0.0032 0.1066 1
Brugia malayi Pyruvate kinase, muscle isozyme 0.0032 0.1066 0.1449
Plasmodium falciparum pyruvate kinase 0.0032 0.1066 1
Mycobacterium leprae Probable pyruvate kinase PykA 0.0032 0.1066 0.5
Loa Loa (eye worm) hypothetical protein 0.0032 0.1066 0.1399
Schistosoma mansoni pyruvate kinase 0.0032 0.1066 0.1066
Schistosoma mansoni transcription factor LCR-F1 0.0036 0.1307 0.1307
Wolbachia endosymbiont of Brugia malayi exonuclease III 0.0019 0.0147 0.5
Loa Loa (eye worm) hypothetical protein 0.0028 0.0785 0.0972
Loa Loa (eye worm) hypothetical protein 0.0023 0.0403 0.039
Mycobacterium tuberculosis Probable pyruvate kinase PykA 0.0032 0.1066 1
Echinococcus granulosus pyruvate kinase 0.0032 0.1066 0.1066
Schistosoma mansoni pyruvate kinase 0.0032 0.1066 0.1066
Loa Loa (eye worm) pyruvate kinase 0.0032 0.1066 0.1399
Loa Loa (eye worm) MH2 domain-containing protein 0.0116 0.6713 1
Brugia malayi hypothetical protein 0.0036 0.1307 0.1815
Trypanosoma cruzi pyruvate kinase 2, putative 0.0032 0.1066 1
Brugia malayi hypothetical protein 0.0028 0.0785 0.1025
Entamoeba histolytica hypothetical protein 0.0036 0.1307 1
Entamoeba histolytica hypothetical protein 0.0036 0.1307 1
Plasmodium vivax AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative 0.0019 0.0147 0.1379
Echinococcus multilocularis pyruvate kinase 0.0032 0.1066 0.1066
Onchocerca volvulus Pyruvate kinase homolog 0.0032 0.1066 0.5
Echinococcus multilocularis Basic leucine zipper (bZIP) transcription 0.0036 0.1307 0.1307
Toxoplasma gondii LsmAD domain-containing protein 0.0028 0.0785 0.7367
Plasmodium falciparum ataxin-2 like protein, putative 0.0028 0.0785 0.7367
Leishmania major pyruvate kinase 0.0032 0.1066 1
Schistosoma mansoni ap endonuclease 0.0019 0.0147 0.0147

Activities

No activities found for this compound.

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.